Chemoinformaics analysis of 10-Hydroxy-6,10-epoxy-7(14)-isodaucane
| Molecular Weight | 238.371 | nRot | 1 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 13 |
| Exact Molecular Weight | 238.193 | nRing | 3 |
| Solubility: LogS | -4.272 | nHRing | 2 |
| Solubility: LogP | 3.953 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 43.9906 |
| nHD | 1 | BPOL | 27.8194 |
| QED | 0.76 |
| Synth | 5.353 |
| Natural Product Likeliness | 2.781 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.565 |
| MDCK | 0.0000334 |
| BBB | 0.218 |
| PPB | 0.954047 |
| VDSS | 1.611 |
| FU | 0.0357421 |
| CYP1A2-inh | 0.085 |
| CYP1A2-sub | 0.796 |
| CYP2c19-inh | 0.041 |
| CYP2c19-sub | 0.95 |
| CYP2c9-inh | 0.178 |
| CYP2c9-sub | 0.073 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.302 |
| CYP3a4-inh | 0.237 |
| CYP3a4-sub | 0.801 |
| CL | 17.936 |
| T12 | 0.122 |
| hERG | 0.057 |
| Ames | 0.008 |
| ROA | 0.122 |
| SkinSen | 0.284 |
| Carcinogencity | 0.049 |
| EI | 0.092 |
| Respiratory | 0.951 |
| NR-Aromatase | 0.207 |
| Antiviral | Yes |
| Prediction | 0.862874 |